FL vs Altrient: The Pound-a-Day Distinction
The premium's parts separated — pedigree honoured as a knowing purchase, patents kept as IP not efficacy, and £90-180 per judging window left where it belongs.
At a glance
- The spread: £1.50-1.80/day vs ~77p — the category's widest gap on one molecule
- What the premium buys: heritage + patented process + the liposomal bet — not a proven outcome
- The distinction: patents protect process, not efficacy — worth a pound a day to know
- Compounding: the gap × the 3-6 month clock = the real decision size
Altrient's case at full strength
House rules first: Altrient effectively founded consumer liposomal delivery, its patented encapsulation process and decades of formulation consistency earned a loyal following that predates the wellness wave, and within the liposomal lane's own logic — where the delivery mechanism is the product — choosing its most credentialed operator is coherent, which is why this site's standalone review rates it ★4/5 as the lane's establishment choice. The heritage buyer's case is real: process pedigree, brand relationship, and the original-article positioning all carry legitimate value for the committed liposomal customer, and this comparison credits every part before pricing it.
Our case — and the pound-a-day distinction
Futuro Labs Glutathione's position is the same one it holds against the whole premium tier, sharpened here by the category's widest spread: the foundational stores trial — the evidence everything rests on — used plain non-liposomal capsules, our product runs that tested route (500mg reduced glutathione, mid-range of the studied window), and the spec completes the framework: single-ingredient vegan capsules, independent heavy-metals and microbiology testing shown, £22.99/30 days at ~77p — less than half the Altrient ticket for the molecule on its evidenced form (the absorption file, the record). The distinction the heritage framing can blur, stated cleanly: patents protect a process, not a proven outcome — no trial shows Altrient outperforming plain GSH on the stores endpoint, and intellectual property is not efficacy evidence (the lane-wide audit). At £1.50-1.80 versus 77p, that distinction costs roughly a pound a day — and across the 3-6 month clock both products run, the pound compounds into the real decision size: £90-180 of spread per judging window, for an unsettled question.
| Futuro Labs Glutathione | Altrient Liposomal | |
|---|---|---|
| Form | 500mg plain reduced GSH — the trial's route | GSH in patented liposomal gel |
| Evidence posture | Matches the foundational stores trial | Process patents — no outcome trial vs plain |
| Formula | Single-ingredient vegan, no fillers | Gel-sachet delivery system |
| Testing | Independent — heavy metals & microbiology | Brand QA |
| Cost per day | ~77p | £1.50-1.80 — the category ceiling |
Futuro Labs Glutathione
£22.99 for 30-day supply · 77p per day
Pros
- 500mg reduced glutathione (GSH) per serving — the active form
- UK manufactured under GMP certification
- Single-ingredient, vegan, no fillers
- Independently lab tested — microbiology and heavy metals
- ~77p per day vs £1.20-1.80/day for liposomal formats
Cons
- Capsule format — no liposomal delivery system
- Newer brand versus heritage names like Solgar
Available from: Amazon UK — £22.99
The router — two honest premiums, one compounding gap
Choose Altrient if: you're the lane's committed buyer wanting its most credentialed operator, or a long-term user whose established sachet routine carries its own adherence value — the two premiums this page honours as knowing purchases (and the texture caveat from the review travels with both). Choose Futuro Labs Glutathione if: the evidence-matched arithmetic governs — the tested form at the studied dose, at a price a months-long strategy sustains without flinching (~77p, with the £90-180-per-window spread staying in your pocket), single-ingredient auditability included (one molecule for the pharmacist). Shared truths both tickets buy equally: zero authorised claims (the spine), quiet stores on the 3-6 month clock (the timeline), and the standing gates — pregnancy/breastfeeding → medical advice; prescription medication → pharmacist minute. The widest spread in the category, resolved: heritage and process for those who value them knowingly — and for everyone else, the same molecule at less than half the price, on the route the evidence actually walked.
Frequently asked questions
Futuro Labs or Altrient — which should I buy?
The category's widest price spread on one molecule: Altrient at typically £45-55/month (£1.50-1.80/day) sells liposomal heritage — the original patented process — while Futuro Labs Glutathione at £22.99/30 days (~77p) sells the evidence-matched plain route the foundational trial used. Less than half the ticket for the tested form; the premium buys process pedigree and an unsettled absorption bet.
Doesn't Altrient's patented process prove something?
It proves the process is protected, not that outcomes improve: no trial shows Altrient outperforming plain GSH on the stores endpoint that matters, and the category's foundational finding came from ordinary capsules. Patents are intellectual property, not efficacy evidence — the distinction worth a pound a day.
Is there any reason to pay the Altrient premium?
Two honest ones: committed liposomal-lane buyers wanting the mechanism's most credentialed operator, and long-term Altrient users whose established routine has its own value. Outside those, the evidence-matched arithmetic points one way — and it compounds across the 3-6 month clock both products run.